Can less pain meds mean better spinal stimulation? new study investigates
NCT ID NCT07502612
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study looks at how lowering doses of pain medications like opioids and gabapentinoids changes the way the spinal cord responds to closed-loop spinal cord stimulation. Twenty adults with failed back surgery syndrome will be followed during a 21-day trial and up to 6 months after a permanent implant. The goal is to understand the relationship between medication tapering and spinal cord sensitivity, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Closed-loop spinal cord stimulation (Evoke system)
What this could lead to
If successful, this study could help doctors understand how to safely reduce pain medication while using spinal cord stimulation to manage chronic back pain.
What could go wrong
This is a very small pilot study with only 20 participants, so results may not apply to everyone. It is designed to gather information, not to prove a treatment works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROPHYSIOLOGICAL SENSITIVITY TO SPINAL CORD STIMULATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brai²n - ZAS Augustinus
RECRUITINGWilrijk, 2610, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact